Holding of The first symposium on immune cell therapy in cancer
According to councils public relations and international affairs, the first symposium on immune cell therapy in cancer held with presence of Dr. Hamidieh at digestive diseases research institute.
According to councils public relations and international affairs, the first symposium on immune cell therapy in cancer held with presence of Dr. Hamidieh at digestive diseases research institute.
Dr. Majidzadeh at the beginning of the meeting described the recent activities of the digestive diseases research In 3 fields of research, education and therapeutic services.
Dr.Hamidieh secretary of council for development of stem cell sciences and technologies told about the importance of proper direction in clinical trials and said, "Using of engineered immune cells like CAR T-Cells, Natural Killer cells and Dendritic cells all promise new treatments for cancer. Immune cell therapy of cancer has been considered the most important progress of the year according to Science publication".
He added, "This field of cell therapy is one of the priorities of the council for development of stem cell sciences and technologies and it enable us to observe development of our country in new treatments for cancer. Until 17 February 2016, 323 clinical trials have been done by using dendritic cells. General Electric Company which manufactures bioreactors in London, has estimated the profit of cell therapy treatment of cancer more than 10 billion dollars."
He mentioned an increase to cell products and stated, "Treatment of cancer with cell therapy will definitely create a revolution in this field".
Dr. Sadeghi talked about immune cell therapy for cancers and stated, "immune system has a complicated system which are in interaction with each other. It is more that T and B cells".
Dr. Aghdami discussed about standards, regulations and commercialization and he also reported about CAR-T Cells.
Dr. Hajati mentioned immunotherapies with T-Cells and said, "nowadays various methods of immunotherapies in cancer for treatment of patients which regular therapies has not shown enough strength have been developed and it brings new hope in treatment of cancer.
Next Dr. Rahbarizadeh presented his report on treatment of cancers with engineered immune cells.
Dr. Amirkhani mentioned holding of the first national festival and international congress on stem cell and regenerative medicine on 19-21 May 2016 and stated, "This festival includes various parts: International congress, Fair and Tech market, Students Olympiad, National award and more."
At the end Dr Hamidieh told about animal farm project in Kerman and also activities of different working groups in the council for development of stem cell sciences and technologies.
He said," It is necessary to invest in sciences which our distance is minimum with other parts of the world therefore we could find a place in international market. Regenerative medicine and cell therapy are few examples".
ارسال به دوستان